HDAC6在线粒分裂过程中调解瘤发生和向性失活剂的发展
Jie Peng1, Hongyan Liu2, Yujing Liu1
1Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, PR China.
Bioorganic chemistry
|September 17, 2024
概括
基斯脱乙酶6 (HDAC6) 在癌症发育中至关重要. 本综述总结了参与细胞分裂的HDAC6-关联蛋白质,并讨论了针对癌症治疗HDAC6的潜在药物.
科学领域:
- 表观遗传学和分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 表观遗传修饰,如脱乙化,是癌症发展的关键调节剂.
- 海斯脱乙酶6 (HDAC6) 通过各种细胞功能参与致癌.
- 虽然HDAC6抑制剂在诱导线粒停滞方面表现有前途,但潜在的机制需要进一步阐明.
研究的目的:
- 审查和综合有关HDAC6-关联蛋白质的信息,这些蛋白质对线粒分裂至关重要.
- 讨论针对HDAC6.6的治疗剂的当前情况.
- 为了解HDAC6在瘤发生和细胞分裂中的作用提供见解.
主要方法:
- 文献综述和对HDAC6.6现有研究的综合.
- 在线分裂过程中与HDAC6相互作用的蛋白质的分析.
- 对HDAC6抑制剂的临床前和临床研究的综述.
主要成果:
- HDAC6与许多蛋白质相互作用,这些蛋白质在线索性进展中起着至关重要的作用.
- HDAC6的失调有助于不受控制的细胞增殖和癌症.
- HDAC6 抑制剂已经显示出阻止癌细胞分裂的潜力.
结论:
- 在癌症治疗中,HDAC6是重要的标,因为它在线粒分裂和瘤发生中的作用.
- 了解HDAC6相关蛋白质可以揭示新的治疗策略.
- 进一步开发HDAC6向剂对癌症治疗具有前景.
相关概念视频
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


